Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of reperfusion injury in lung transplantation for cystic fibrosis by targeting IL-8
2009-013340-36Phase 2Terminated
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of reparixin in cystic fibrosis (CF) and ischemia-reperfusion injury (IRI), sponsored by Mario Negri Institute for Pharmacological Research. Started Dec 2009; status: terminated.
02
Drugs
reparixin
03
Conditions
cystic fibrosis (CF)ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on 2009-013340-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013340-36.